Keyphrases
Chronic Myeloid Leukemia
100%
Human Leukocyte Antigen
100%
Unrelated Donor
100%
Allogeneic Bone Marrow Transplantation
100%
Graft-versus-host Disease (GvHD)
27%
Bone Marrow Transplantation
18%
Cyclosporine
18%
Leukemia Patients
18%
Acute Leukemia
9%
Corticosteroids
9%
Chronic Phase
9%
Methotrexate
9%
Myelodysplasia
9%
Non-relapse Mortality
9%
2-year Survival
9%
Regression Analysis
9%
Leukemia Diagnosis
9%
DRB1
9%
Donor Engraftment
9%
Age of Diagnosis
9%
Adult Human Bone Marrow
9%
Graft-versus-host Disease Prophylaxis
9%
Adverse Risk
9%
Human Leukocyte antigen-A
9%
Transplanting Time
9%
T Cell Depletion
9%
Risk Factors for Survival
9%
Medicine and Dentistry
Bone Marrow Transplantation
100%
Chronic Myelogenous Leukemia
100%
Human Leukocyte Antigen
100%
Acute Graft Versus Host Disease
18%
Cyclosporine
18%
T Cell
9%
Transplantation
9%
Engraftment
9%
Acute Leukemia
9%
Prophylaxis
9%
Chronic Graft Versus Host Disease
9%
Myelodysplastic Syndrome
9%
Graft Versus Host Reaction
9%
Methotrexate
9%
Non-Relapse Mortality
9%